Skip to content

C4X teams up with PhoreMost to look for potential Parkinson’s treatments

Calculus Capital portfolio company C4X Discovery Holdings plc has teamed up with fellow UK-based biopharma, PhoreMost, to look for treatments for Parkinson’s Disease and other ‘undruggable’ diseases. The pair will take potentially useful compounds already identified by C4X’s Taxonomy 3 platform and run them through PhoreMost’s SITESEEKER screening platform. That data can then be exploited by … Continued

Avvio marks further UK growth

Global technology provider Avvio has upsized its London offices and is making a number of new appointments as it continues its impressive global growth. Located in the heart of the capital – nestled between Charing Cross and Leicester Square – Avvio’s new UK base is twice as big as the company’s previous residence and reflects … Continued

UK Creative Content EIS Fund is now open

The UK Creative Content EIS Fund is now open for investment following the official launch event of the Fund on 10 June. Game of Thrones star Natalie Dormer, who spoke at the launch event, has hailed the launch of the BFI-associated UK Creative Content EIS Fund as “an important event for the UK screen industry”. … Continued

Calculus Capital and CEO John Glencross win at the EISA 25th Year Anniversary Awards

At a prestigious awards ceremony in the Banqueting House, Whitehall on Thursday 20th June, Calculus Capital were delighted to take home two awards. The first award was for our Chief Executive John Glencross, who picked up Outstanding Contribution to the EIS Industry by an Individual. Calculus Capital won Outstanding Contribution to EIS Investment Management by … Continued

Spotlight On: Axol Bioscience

As part of our ‘Spotlight On’ series, we focus on Axol Bioscience, a company who provides human cell culture systems for medical research, disease modelling and drug development. Axol Bioscience supplies high quality human cells, both healthy and diseased, to many of the world’s biggest pharmaceutical companies and best known research institutions. Axol generates stem … Continued

Scancell raises £3.9m from Vulpes Life Sciences

[iframe id=”” align=”left” mode=”normal” autoplay=”yes” parameters=””] Scancell, the developer of novel immunotherapies for the treatment of cancer, today announces that it has raised £3.9m at a price of 5 pence per share from Vulpes Life Sciences Fund (“Vulpes”) under existing shareholder authorities. Vulpes Investment Management was founded in 2011 by Stephen and Martin Diggle and … Continued

Money Dashboard integrates with three new providers

Money management app Money Dashboard has released integrations with three new account providers – Revolut, Chip and Marcus by Goldman Sachs. The integrations help consumers track spending and progress towards their savings goals in real time. Money Dashboard is the first UK personal finance app to release an integration with Revolut and follows the recent integration … Continued